Use of intramuscular triamcinolone acetonide in intermediate responders to janus kinase inhibition for alopecia areata: Case report

• Huvudupphovsmän: Erinolaoluwa F Araoye (Författare, medförfattare), Crystal Aguh (Författare, medförfattare)
• Materialtyp: Bok
• Publicerad: Wolters Kluwer Medknow Publications, 2021-01-01T00:00:00Z.
• Ämnen: article
• Länkar: Connect to this object online.

Janus kinase (JAK) inhibitors have been identified as an effective treatment option for severe alopecia areata (AA), but response is variable among patients. Intramuscular triamcinolone acetonide (IMTA), which has a greater bioavailability than other forms of steroids, has been used effectively to t...